RE:Cognition (Chicago) — Chicago, Illinois

RE:Cognition (Chicago) is a clinical research site located in Chicago, Illinois, United States 60611.

Crixeo Health Trust Score: 53/100 (POOR). This profile has not yet been claimed by the site owner.

RE:Cognition (Chicago) has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Alzheimers Disease.

Sponsors: Hoffmann-La Roche.

Sponsor Feasibility Report

Trust Score: 53/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for RE:Cognition (Chicago)?

RE:Cognition (Chicago) has a Crixeo Trust Score of 53/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has RE:Cognition (Chicago) conducted?

RE:Cognition (Chicago) has 2 clinical trials on record, with 2 currently active. Their work covers Alzheimers Disease.

Is RE:Cognition (Chicago) accredited by Crixeo Health?

RE:Cognition (Chicago) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about RE:Cognition (Chicago)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.